Literature DB >> 18467307

Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis.

Mamoon A Aldeyab1, Dominique L Monnet, José María López-Lozano, Carmel M Hughes, Michael G Scott, Mary P Kearney, Fidelma A Magee, James C McElnay.   

Abstract

OBJECTIVES: Methicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen worldwide. A wide range of factors have been suggested to influence the spread of MRSA. The objective of this study was to evaluate the effect of antimicrobial drug use and infection control practices on nosocomial MRSA incidence in a 426-bed general teaching hospital in Northern Ireland.
METHODS: The present research involved the retrospective collection of monthly data on the usage of antibiotics and on infection control practices within the hospital over a 5 year period (January 2000-December 2004). A multivariate ARIMA (time-series analysis) model was built to relate MRSA incidence with antibiotic use and infection control practices.
RESULTS: Analysis of the 5 year data set showed that temporal variations in MRSA incidence followed temporal variations in the use of fluoroquinolones, third-generation cephalosporins, macrolides and amoxicillin/clavulanic acid (coefficients = 0.005, 0.03, 0.002 and 0.003, respectively, with various time lags). Temporal relationships were also observed between MRSA incidence and infection control practices, i.e. the number of patients actively screened for MRSA (coefficient = -0.007), the use of alcohol-impregnated wipes (coefficient = -0.0003) and the bulk orders of alcohol-based handrub (coefficients = -0.04 and -0.08), with increased infection control activity being associated with decreased MRSA incidence, and between MRSA incidence and the number of new patients admitted with MRSA (coefficient = 0.22). The model explained 78.4% of the variance in the monthly incidence of MRSA.
CONCLUSIONS: The results of this study confirm the value of infection control policies as well as suggest the usefulness of restricting the use of certain antimicrobial classes to control MRSA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467307     DOI: 10.1093/jac/dkn198

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  39 in total

1.  Antimicrobial stewardship.

Authors:  Shira Doron; Lisa E Davidson
Journal:  Mayo Clin Proc       Date:  2011-11       Impact factor: 7.616

2.  Measuring the externality of antibacterial use from promoting antimicrobial resistance.

Authors:  Klaus Kaier; Uwe Frank
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

3.  A point prevalence survey of antibiotic prescriptions: benchmarking and patterns of use.

Authors:  Mamoon A Aldeyab; Mary P Kearney; James C McElnay; Fidelma A Magee; Geraldine Conlon; Dianne Gill; Peter Davey; Arno Muller; Herman Goossens; Michael G Scott
Journal:  Br J Clin Pharmacol       Date:  2011-02       Impact factor: 4.335

4.  Correlation between antibiotic consumption and resistance of bloodstream bacteria in a University Hospital in North Eastern Italy, 2008-2014.

Authors:  Marta Mascarello; Omar Simonetti; Anna Knezevich; Ludovica Ilaria Carniel; Jacopo Monticelli; Marina Busetti; Paolo Schincariol; Lucio Torelli; Roberto Luzzati
Journal:  Infection       Date:  2017-03-06       Impact factor: 3.553

5.  Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated diarrhea in hospitalized patients.

Authors:  Mamoon A Aldeyab; Stephan Harbarth; Nathalie Vernaz; Mary P Kearney; Michael G Scott; Chris Funston; Karen Savage; Denise Kelly; Motasem A Aldiab; James C McElnay
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

6.  Relationship between antibiotic consumption and Clostridium difficile-associated diarrhea: an epidemiological note.

Authors:  Klaus Kaier; Uwe Frank
Journal:  Antimicrob Agents Chemother       Date:  2009-10       Impact factor: 5.191

Review 7.  Antibiotic resistance and its cost: is it possible to reverse resistance?

Authors:  Dan I Andersson; Diarmaid Hughes
Journal:  Nat Rev Microbiol       Date:  2010-03-08       Impact factor: 60.633

8.  Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections.

Authors:  Jill M Butterfield; Brian T Tsuji; Jack Brown; Elizabeth Dodds Ashley; Dwight Hardy; Kristen Brown; Alan Forrest; Thomas P Lodise
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

Review 9.  Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance.

Authors:  Vered Schechner; Elizabeth Temkin; Stephan Harbarth; Yehuda Carmeli; Mitchell J Schwaber
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

10.  Methicillin-resistant and -susceptible Staphylococcus aureus infections in dogs.

Authors:  Meredith C Faires; Michelle Traverse; Kathy C Tater; David L Pearl; J Scott Weese
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.